P-CRP for Recent-Onset Severe Trauma (NCT07360990) | Clinical Trial Compass
CompletedNot Applicable
P-CRP for Recent-Onset Severe Trauma
Turkey (Türkiye)43 participantsStarted 2025-03-05
Plain-language summary
The purpose of this retrospective study was to evaluate the effectiveness of a new psychotherapy technique called Psychological Cognitive Reprocessing Procedure (P-CRP) in treating trauma symptoms. The P-CRP intervention was developed and manualized by the principal investigator (Z.B.Baydar). Participants were randomly assigned to either the P-CRP intervention group, an active control group, or a waitlist condition. The study aimed to determine if this new method, which focused on episodic buffer processing, significantly reduced trauma-related psychological distress compared to standard approaches. Data collected during the intervention phase were analyzed to assess the efficacy of the P-CRP technique.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Individuals were excluded if they had:
1. An Adverse Childhood Experiences (ACE) score greater than 7.
2. A history of psychotic disorder or bipolar disorder.
3. Current suicide risk.
4. Substance use disorder.
5. Prior therapeutic contact with the researcher.
6. A target traumatic event that had occurred more than one year earlier.
7. Not meeting clinical DSM-5 criteria for PTSD during the clinician-administered semi-structured interview, regardless of initial self-report scores.
8. Current participation in any other form of psychotherapy or psychiatric intervention.
Individuals were included if they had:
1. Meeting DSM-5 criteria for PTSD symptoms (verified by IES-R scores and clinician-led semi-structured interview).
2. Having experienced a target traumatic event or loss within the past 12 months.
3. Willingness to provide informed consent and participate in all intervention sessions.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.